Spots Global Cancer Trial Database for stage iv nasopharyngeal carcinoma
Every month we try and update this database with for stage iv nasopharyngeal carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Olfactory Training in Improving Sense of Smell After Radiation Therapy in Patients With Paranasal Sinus or Nasopharyngeal Cancer | NCT03049358 | Stage 0 Nasopha... Stage 0 Paranas... Stage I Nasopha... Stage I Paranas... Stage II Nasoph... Stage II Parana... Stage IIA Nasop... Stage IIB Nasop... Stage III Nasop... Stage III Paran... Stage IV Nasoph... Stage IV Parana... Stage IVA Nasop... Stage IVA Paran... Stage IVB Nasop... Stage IVB Paran... Stage IVC Nasop... Stage IVC Paran... | Physiologic Tes... Quality-of-Life... Sham Interventi... Therapeutic Pro... rose essential ... lemon essential... clove essential... eucalyptus esse... canola oil plac... | 19 Years - | Stanford University | |
| Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery | NCT02538510 | Head and Neck S... Recurrent Nasal... Recurrent Nasop... Recurrent Saliv... Squamous Cell C... Stage III Major... Stage III Nasal... Stage III Nasop... Stage IV Nasoph... Stage IVA Major... Stage IVA Nasal... Stage IVB Major... Stage IVB Nasal... Stage IVC Major... Stage IVC Nasal... | Laboratory Biom... Pembrolizumab Vorinostat | 18 Years - | University of Washington | |
| Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer | NCT04231864 | Epstein-Barr Vi... Metastatic Naso... Recurrent Nasop... Stage III Nasop... Stage IV Nasoph... Stage IVA Nasop... Stage IVB Nasop... | Durvalumab Epacadostat | 18 Years - | University of California, San Francisco | |
| Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | NCT01616849 | Stage IV Nasoph... | cisplatin and 5... | 18 Years - 70 Years | Sun Yat-sen University | |
| Study of Chemotherapy Combined With Nimotuzumab in Untreated Metastatic Nasopharyngeal Carcinoma | NCT01616849 | Stage IV Nasoph... | cisplatin and 5... | 18 Years - 70 Years | Sun Yat-sen University | |
| GC Regimen Chemotherapy Plus CIK Cells for Metastatic Nasopharyngeal Carcinoma | NCT01655628 | Stage IV Nasoph... | GC chemotherapy... GC chemotherapy... | 18 Years - 60 Years | Sun Yat-sen University | |
| Durvalumab and Epacadostat for Treatment of Unresectable, Recurrent, or Metastatic Epstein-Barr Virus Positive Nasopharyngeal Cancer | NCT04231864 | Epstein-Barr Vi... Metastatic Naso... Recurrent Nasop... Stage III Nasop... Stage IV Nasoph... Stage IVA Nasop... Stage IVB Nasop... | Durvalumab Epacadostat | 18 Years - | University of California, San Francisco | |
| PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies | NCT03044743 | Stage IV Gastri... Stage IV Nasoph... T-Cell Lymphoma... Stage IV Adult ... Stage IV Diffus... | Fludarabine Cyclophosphamid... Interleukin-2 | 18 Years - 75 Years | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
